Q Bio’s Post

Heart Attack Diagnostics Market Expected to Hit a Valuation of US$ 18.6 Billion During 2024-2032, CAGR of 6.66% | IMARC Group The global heart attack diagnostics market size reached US$ 10.4 Billion in 2023. Looking forward, IMARC Group expects the market to reach US$ 18.6 Billion by 2032, exhibiting a growth rate (CAGR) of 6.66% during 2024-2032. Request a Sample Report: https://lnkd.in/dz-AxDqp The increasing occurrences of cardiovascular diseases, emerging technological advancements in diagnostic tools, implementation of favorable government initiatives, improving healthcare infrastructure, and the integration of artificial intelligence (AI) and machine learning (ML) are some of the major factors propelling the market. Want to Know More about the Market - Explore Full Report: https://lnkd.in/gpEnVXDD #HeartAttackDiagnosticsMarket #HeartAttackDiagnostics #HeartAttackDiagnosticsCompanies #IMARCGroup #MarketResearchReport #MarketReport #IndustryReport #USA #Marketing #Business #MarketResearch #MarketStrategy

Heart Attack Diagnostics Market Predicted to Hit US$ 14.7 Billion by 2028, Growing at a CAGR of 7.40% during 2023-2028 The global heart attack diagnostics market size reached US$ 9.7 Billion in 2022. Looking forward, IMARC Group expects the market to reach US$ 14.7 Billion by 2028, exhibiting a growth rate (CAGR) of 7.40% during 2023-2028. Request a Sample Report: https://lnkd.in/dz-AxDqp The increasing occurrences of cardiovascular diseases, emerging technological advancements in diagnostic tools, implementation of favorable government initiatives, improving healthcare infrastructure, and the integration of artificial intelligence (AI) and machine learning (ML) are some of the major factors propelling the market. Want to Know More about the Market - Explore Full Report: https://lnkd.in/ddHaTmWz #HeartAttackDiagnosticsMarket #HeartAttackDiagnostics #HeartAttackDiagnosticsCompanies #IMARCGroup #MarketResearchReport #MarketReport #IndustryReport #USA #Marketing #Business #MarketResearch #MarketStrategy

Artificial intelligence-enhanced electrocardiography derived body mass index as a predictor of future cardiometabolic disease - npj Digital Medicine Summary: #ArtificialIntelligence in healthcare is revolutionizing the way we predict cardiometabolic diseases. A recent study has shown that AI-enhanced electrocardiography can accurately predict future cardiometabolic disease based on body mass index. This innovative approach has the potential to improve patient outcomes and streamline healthcare processes. #PredictiveAnalytics #CardiometabolicDisease #HealthcareAI Key Points: #StudyFindings: A study found that AI-enhanced electrocardiography can predict future cardiometabolic disease with high accuracy. #BodyMassIndex: The AI model uses body mass index as a key predictor for cardiometabolic disease. #Benefits: This technology has the potential to improve patient outcomes and optimize healthcare resources. #Future ai.mediformatica.com #model #obesity #ukbiobank #digital #cardiometabolicdisease #medical #cardiac #intelligence #artificialintelligence #medicine #found #bethisraeldeaconemedicalcenter #digitalhealth #healthit #healthtech #healthcaretechnology @MediFormatica (https://buff.ly/3VDvyxE)

🌟 Exciting News! 🌟 On May 28th in Florence, Italy, during the AFFIRMO project meeting, we launched a new collaborative cluster focused on cardiac disease and multimorbidity management! 💖🔬 The @Horizon Europe projects AFFIRMO, ARISTOTELES EU Project, and TARGET EU Project have come together to enhance research, share insights, and innovate for better patient outcomes. This cluster is set to revolutionize how we approach atrial fibrillation (AF) and its comorbidities by leveraging AI, personalized care models, and a holistic approach to patient management. We’re thrilled about the potential of this collaboration and can’t wait to see the amazing advancements it will bring! 🚀💡 Discover more on our website! 🌍✨ https://lnkd.in/ddjhjFT2 #CardiacHealth #Multimorbidity #AIInHealthcare #HorizonEurope #AFFIRMO #ARISTOTELES #TARGET #MedicalInnovation #HealthcareRevolution #ResearchCollaboration #AtrialFibrillation #HeartHealth

Artificial Intelligence (AI) would be a boon for the medical industry, especially for early disease diagnosis. #intuites #AI #healthcare #artificialintelligence #intelligence #doctors #replaced #robots #MedicalIndustry #medical #industry #especially #diagnosis #disease #replace #EarlyDisease #replacedoctors #fb #FacebookPage

ICYMI: Last month, we shared a deep dive into how researchers used a multimodal atlas of disease and AI/ML models on the Enable Medicine platform to uncover 1) therapeutic #mechanismofaction of IL-23 blockade in #psoriasis and 2) biological signatures that stratify #therapeuticresponse in IL-23-treated psoriasis patients. These data-driven insights provided direction for: - Determining better dosing strategies, formulating more durable medications, and potentially uncovering different treatment regimens or combinations to fully suppress disease. AND - Supporting better #patientselection and identifying patients with non-psoriasis diagnoses who may also benefit from IL-23 blockade. Want to catch our next newsletter? Sign-up here so you don't miss out: https://hubs.li/Q02mqSJm0

Artificial Intelligence (AI) would be a boon for the medical industry, especially for early disease diagnosis. #intuites #AI #healthcare #artificialintelligence #intelligence #doctors #replaced #robots #MedicalIndustry #medical #industry #especially #diagnosis #disease #replace #EarlyDisease #replacedoctors #fb #FacebookPage

We take about 12-20 breaths every minute just to keep our bodies functioning properly. It's a reminder of how vital our lungs are to our everyday activities and overall well-being. 🫁   Israeli and U.S. tech powerhouses have joined forces to unveil a groundbreaking AI program that could revolutionize lung disease detection. Medial EarlySign is an Israeli clinical predictive analytics company led by Technion - Israel Institute of Technology alumnus Itai Katzir whose technology is poised to spot lung disease risks faster and more accurately than ever before. https://lnkd.in/evxQnH9w   #TechnionAlumni #TechnionImpact

We see things a little differently around here....👀 At DexaFit Dx, we're leveling up DEXA with AI to make an impact on the chronic diseases impacting millions of lives every day and costing our healthcare system billions of dollars every year. Our mission is to bring awareness to disease risks far before that happens, and inspire you with healthier habits on your journey to an optimal healthspan! #hearthealth #heartdisease #diagnostics #ai #innovation #healthtech #imaging #preventivemedicine

Two AI-powered predictive models from Cedar Gate identified more than $1.4 billion in potential savings for patients at high risk of developing coronary artery disease or congestive heart failure.    These remarkable AI tools give providers and payers the power to find patients before they show up in the ER or hospital after a major cardiac event, and possibly prevent some of the most devastating and costly impacts of heart disease.     The future of healthcare looks promising with predictive AI from Cedar Gate: https://lnkd.in/eWwGXhGp    #heartdisease #prevention #AI #healthcareAI #valuebasedcare #valuerevolution #healthcareIT #thefutureofhealthcare